Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Certain growth factors can promote hair growth in mice by activating hair growth-related proteins.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

FGF-2&D/P nanoparticles can help treat hair loss.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Lower growth factors linked to balding in androgenetic alopecia.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

AGA patients have higher heart disease risk.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

The conclusion is that balancing cost and carbon emissions in hybrid power systems is crucial, especially when high reliability is needed, but the model needs to consider all device efficiencies and distribution losses.

Scalp reduction can treat severe hair loss, but success depends on scalp flexibility and it may cause complications like pain, infection, and cosmetic issues.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

FUE megasession hair transplantation effectively treats large area hair loss with less discomfort and shorter operation time.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Higher levels of DHEA and TNF-α are linked to PCOS symptoms.

Androgens increase growth factors in skin cells, which may lead to acne.